Satisfaction and quality of life with premeal inhaled versus injected insulin in adolescents and adults with type 1 diabetes

Diabetes Care

Volumn 30, Issue 6, 2007, Pages 1399-1405

  Testa, Marcia A ^a   Simonson, Donald C ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ISOPHANE INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; HEALTH STATUS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTICENTER STUDY; OPEN STUDY; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; EATING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN, ISOPHANE; MALE; MIDDLE AGED; OCCUPATIONS; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUALITY OF LIFE;

EID: 34249904117     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1497     Document Type: Article

References (27)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
3. Zgibor JC, Songer TJ, Kelsey SF, Weissfeld J, Drash AL, Becker D, Orchard TJ: The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a crosssectional analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 23:472-476, 2000
4. Muller UA, Femerling M, Reinauer KM, RisseA, Voss M, Jorgens V, Berger M, Muhlhauser I: Intensified treatment and education of type 1 diabetes as clinical routine: a nationwide quality-circle experience in Germany: ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association). Diabetes Care 22 (Suppl. 2):B29-B34, 1999
5. Zambanini A, Newson RB, Maisey M, Feher MD: Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 46:239-246, 1999
6. Mollema ED, Snoek FJ, Heine RJ, van der Ploeg HM: Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med 18:671-674, 2001
7. Quattrin T, Belanger A, Bohannon NJ, Schwartz SL, Exubera Phase III Study Group: Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 27:2622-2627, 2004
8. Skyler JS, Weinstock RS, Raskin P, Yale JF, Barrett E, Gerich JE, Gerstein HC, Inhaled Insulin Phase III Type 1 Diabetes Study Group: Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial. Diabetes Care 28:1630-1635, 2005
9. Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, Chiasson JL, Levin SR: Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 27:2356-2362, 2004
10. Testa MA, Simonson DC: Assessing quality-of-life outcomes. N Engl J Med 334:835-840, 1996
11. Testa MA: Interpretation of quality of life outcomes: issues that affect magnitude and meaning. Medical Care 38:II-166-II-174, 2000
12. Testa MA, Turner RR, Krafcik MB, Simonson DC, Calvo C, Luque-Otero M, the Nifedipine GITS Study Group: Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. J Hypertens 16:1839-1847, 1998
13. Testa MA, Anderson RB, Nackley JF, Hollenberg NK: Quality of life and antihypertensive therapy in men: a comparison of captopril with enalapril. N Engl J Med 328:907-913, 1993
14. Testa MA, Hollenberg NK, Anderson RA, Williams GH: Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine GITS. Am J Hypertens 4:363-373, 1991
15. Anderson RB, Nackley JF, Testa MA: Symptom distress check lists as a component of quality of life measurement: comparing symptom reports with responses to multiple choice questionnaires. Drug Inf J 29:1689S-1707S, 1995
16. Testa MA, Simonson DC: Measuring quality of life in hypertensive patients with diabetes. Postgrad Med J 64 (Suppl. 3):50-58, 1988
17. Testa MA, Simonson DC, Turner RR: Valuing quality of life and improvements in glycemic control in people with type 2 diabetes. Diabetes Care 21 (Suppl. 3):C44-C52, 1998
18. Anderson RB, Testa MA: Symptom distress checklists as a component of quality-of life measurement: comparing prompted reports by patient and physician with concurrent adverse event reports via the physician. Drug Inf J 28:89-114, 1994
19. Testa MA, Turner RR, Simonson DC: Effects of lower blood glucose and reduced inter-day glucose variability on quality of life in type 2 diabetes (Abstract). Diabetes 52 (Suppl. 1):A420, 2003
20. Testa MA, Hayes JF, Turner RR, Simonson DC: Improved quality of life is associated with improved glycemic control in type 2 diabetes: an international, multicultural, multi-center, placebo-control clinical trial (Abstract). Diabetes 49 (Suppl. 1):A73, 2000
21. Testa MA: Quality-of-life assessment in diabetes research: interpreting the magnitude and meaning of treatment effects. Diabetes Spectrum 13:36-41, 2000
22. Dubey SD: Adjustment of p-values for multiplicities of intercorrelating symptoms. Proceedings of the VIth International Society for Clinical Biostatisticians, Düsseldorf, Germany, 1985
23. Armitage P, Parmar M: Some approaches to the problem of multiplicity in clinical trials. Proceedings of the XIIth International Biometrics Conference, Seattle, Washington, 1986
24. Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M: Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 112:559-564, 2003
25. Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P: A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 28:1568-1573, 2005
26. Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH: The effects of antihypertensive therapy on the quality of life. N Engl J Med 314:1657-1664, 1986
27. Andrade SE, Walker AM, Gottlieb LK, Hollenberg NK, Testa MA, Saperia GM, Platt R: Discontinuation of antihyperlipidemic drugs: do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med 332:1125-1131, 1995